Phase II trial of carboplatin, abraxane, and bevacizumab in NSCLC Heist, R. S., Duda, G. D., Sahani, D., Ancukiewicz, M., Fidias, P., Sequist, L. V., Shaw, A. T., Temel, J. S., Lennes, I. T., Neal, J. W., Pennell, N. A., Lynch, T. J., Engelman, J. A., Jain, R. K. AMER SOC CLINICAL ONCOLOGY. 2011

View details for DOI 10.1200/jco.2011.29.15_suppl.e18016

View details for Web of Science ID 000208880304394